221 related articles for article (PubMed ID: 12921398)
1. Optimal and efficient crossover designs under different assumptions about the carryover effects.
Hedayat AS; Stufken J
J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
[TBL] [Abstract][Full Text] [Related]
2. Design and analysis issues for crossover designs in phase I clinical studies.
Boon PC; Roes KC
J Biopharm Stat; 1999 Mar; 9(1):109-28. PubMed ID: 10091913
[TBL] [Abstract][Full Text] [Related]
3. CrossOver: an algorithm for the construction of efficient cross-over designs.
John JA; Russell KG; Whitaker D
Stat Med; 2004 Sep; 23(17):2645-58. PubMed ID: 15316948
[TBL] [Abstract][Full Text] [Related]
4. Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.
Gondaliya J; Divecha J
Int J Biostat; 2018 Nov; 14(2):. PubMed ID: 30471221
[TBL] [Abstract][Full Text] [Related]
5. Crossover versus parallel designs: dose-escalation design comparisons for first-in-human studies.
Yan Z; Hosmane B; Locke C
J Biopharm Stat; 2013; 23(4):804-17. PubMed ID: 23786490
[TBL] [Abstract][Full Text] [Related]
6. Optimal crossover designs for logistic regression models in pharmacodynamics.
Waterhouse TH; Eccleston JA; Duffull SB
J Biopharm Stat; 2006; 16(6):881-94. PubMed ID: 17146986
[TBL] [Abstract][Full Text] [Related]
7. On the role of Baseline measurements for crossover designs under the self and mixed carryover effects model.
Liang Y; Carriere KC
Biometrics; 2010 Mar; 66(1):140-8. PubMed ID: 19432775
[TBL] [Abstract][Full Text] [Related]
8. Optimal crossover designs in the presence of carryover effects.
Laska E; Meisner M; Kushner HB
Biometrics; 1983 Dec; 39(4):1087-91. PubMed ID: 6671121
[TBL] [Abstract][Full Text] [Related]
9. Optimal and/or efficient three treatment crossover designs for five carryover models.
Gondaliya J; Divecha J
J Biopharm Stat; 2020 May; 30(3):445-461. PubMed ID: 31721628
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of alternative statistical models for crossover studies to demonstrate caffeine adjuvancy in the treatment of tension headache.
Koch GG; Amara IA; MacMillan J
J Biopharm Stat; 1994 Nov; 4(3):347-410. PubMed ID: 7881452
[TBL] [Abstract][Full Text] [Related]
11. Assessing the impact of carryover effects on the variances of estimators of treatment differences in crossover designs.
Ozan MO; Stufken J
Stat Med; 2010 Oct; 29(24):2480-5. PubMed ID: 20683837
[TBL] [Abstract][Full Text] [Related]
12. Modelling and design of cross-over trials.
Jones B; Donev AN
Stat Med; 1996 Jul; 15(13):1435-46. PubMed ID: 8841653
[TBL] [Abstract][Full Text] [Related]
13. Tests for inter-subject and total variabilities under crossover designs.
Lee Y; Shao J; Chow SC; Wang H
J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
[TBL] [Abstract][Full Text] [Related]
14. Three-period crossover designs for two treatments.
Ebbutt AF
Biometrics; 1984 Mar; 40(1):219-24. PubMed ID: 6733230
[TBL] [Abstract][Full Text] [Related]
15. Optimal designs for estimating the interesting part of a dose-effect curve.
Miller F; Guilbaud O; Dette H
J Biopharm Stat; 2007; 17(6):1097-115. PubMed ID: 18027219
[TBL] [Abstract][Full Text] [Related]
16. Design and analysis of crossover trials for absorbing binary endpoints.
Nason M; Follmann D
Biometrics; 2010 Sep; 66(3):958-65. PubMed ID: 19930189
[TBL] [Abstract][Full Text] [Related]
17. The place of the crossover design in infertility trials: a maximum likelihood approach.
McDonnell J; Goverde AJ; Vermeiden JP
Hum Reprod; 2004 Nov; 19(11):2537-44. PubMed ID: 15459169
[TBL] [Abstract][Full Text] [Related]
18. On assessment of bioequivalence under a higher-order crossover design.
Chow SC; Liu JP
J Biopharm Stat; 1992; 2(2):239-56. PubMed ID: 1300216
[TBL] [Abstract][Full Text] [Related]
19. The impact of baseline covariates on the efficiency of statistical analyses of crossover designs.
Yan Z
Stat Med; 2013 Mar; 32(6):956-63. PubMed ID: 22903413
[TBL] [Abstract][Full Text] [Related]
20. On the designs of thorough QT/QTc clinical trials.
Tsong Y
J Biopharm Stat; 2013; 23(1):43-56. PubMed ID: 23331220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
